Part of funding portal member: truCrowd, Inc.
Mobile Menu

Greenzone Pharms LLC

First CBD Hemp Processor In Illinois

76% funded (of minimum target)

Closed on 12/01/21

$7,620

amount committed 

$10k - $1070k

funding goal 

Regulation CF

exemption used 

$5,000,000

pre money valuation 

$200.00

min investment 

33

investors 


Security Type
Units of Revenue Participation
Revenue Participation: 10%
Potential Return: 3X (3 times)
Early Buyback Potential Return: 5X

Who are we

Greenzone is a licensed grower of hemp in the state of Wisconsin and a CBD extractor and processor in the State of Illinois. From cloning and genetics to Co2 Supercritical oil extraction to brand development of tinctures (drops), gummies, lotions, and other CBD infused products, Greenzone is truly a verticle soil-to-shelf company.

 

Money had this to say in its October 3, 2019 Article online (money.com):

 

"CBD is in the middle of a business boom. Sometimes known as “the other weed,” cannabis-derived cannabidiol is quickly catching on in products marketed and sold throughout the United States, ranging from infused tinctures and oils to premium chocolate bars and even a $50 jar of “rejuvenating” clay mask ... that utilize the anti-inflammatory properties of the cannabinoid to reduce redness and breakouts.

The CBD industry is already worth $1 billion, and Wall Street experts think it could reach 16billion by 2025. Meanwhile, celebrities are quickly flocking to this alternative-pot market,"

 

Think of CBD as the Medical "PART" of Medical Marijuana.

 

CBD is truely an amazing molecule, and millions of people are learning about it every day. There is a lack of education and properly formulated quality products on the market. The FDA recently tested 23 brands and only 3 provided what the packaging claimed.  Greenzone is here to change that, we will educate the consumer and also provide a truly high-quality 3rd party Lab tested CBD product to the customer through retail and online sales.

 

More and more Americans are turning to CBD to address their medical problems naturally. Below you can see who is using CBD and for what purposes.

 

We proudly call our CBD oil the Gold Standard oil. With third party testing, 110% formulation procedures as well as beautifully designed packaging, Greenzone has a significant advantage in this aggressively growing industry. 

 

 

Greenzone has been invited to speak about CBD in front of the Chicago Fraternal Order of Police, as well as at the Illinois Rural Development Expo, we even developed a product called First Responder, for Police, Firefighters, and Paramedics to ensure Zero THC CBD oil can be used safely without any career drug test failures.

 

Also, Greenzone has developed a huge audience of Hemp Industry peers by founding the Wisconsin Hemp Cooperative and the Illinois Hemp Cooperative facebook pages giving us direct access to over 1000 Hemp Growers, Processors and CBD Product companies.

 

Growing our distribution network is a key goal we intend to expand. We currently are in a handful of 7/11 stores and vape stores. We intend to expand that network to over 1000 retail locations.

 

The pilot store in Schaumburg IL lays out the foundation for future retail distribution on platform sales. Off-platform distribution would be conducted through independently owned and branded CBD vape and health-minded stores.

 

 

The CBD Hemp Oil market is one of the fastest-growing industries in the United States and across the Globe. Due to the benefits of CBD, it has been called Nature's Miracle and for good reason, it really works. We are proud of our products great effects and the lives it has changed.

 

According to Brightfield Group, sales of hemp-derived CBD products almost doubled to $170 million in 2016. Experts have already suggested that it will become a billion-dollar industry by 2020 or 2021.

 

The Hemp Industries Association (HIA) reported total U.S. retail sales of hemp products of nearly $700 million in 2016. HIA claims that U.S. hemp retail sales have increased by about 10% to more than 20% annually since 2011. Much of this growth is attributable to sales of hemp-based body products, supplements, and foods. Combined, these categories accounted for more than two-thirds of the value of U.S. retail CBD sales in 2016.

 

According to a new report “Global State Of Hemp: 2019 Industry Outlook” from New Frontier Data, U.S. sales of hemp products estimated at about $1 billion in 2018, are projected to grow 27% annually to reach $22 billion by 2022.

 

Hemp imports to the United States – consisting of hemp seeds and fibers often used as inputs for use in further manufacturing – totaled $67.3 million in 2017, 57% decrease in seed imports from the previous year, and the first half of 2018 puts the import market on pace for a 20% decrease. This downward trend is expected to continue as the U.S. hemp market continues to mature and expand.

 

 

There are many CBD companies but most are marketing companies with lower than promised CBD levels. Greenzone plans to educate the consumer and provide the Gold Standard in CBD products.

 

We intend to take advantage of the new interest in Big Box Stores by actively marketing to stores such as Walmart, CVS, and Walgreens.

 

Our revenue streams include: 

  • Farm ready Hemp Clones
  • Farm Co2 Supercritical Extraction
  • Toll processing of distillate, Isolate and T-Free Distillate
  • Private label and White label Manufacturing for other CBD companies
  • Brand Development and Formulations
  • Powder Designer CBD encapsulation using our 1200 capsule per min. encapsulation machine
  • Hemp Industry Consulting and CBD Product Development services

 

 

With over 25 years as an entrepreneur, our CEO Dan Marlow has brought many companies to market in the High Tech Sector. Including, Internet, Bitcoin, and Voice Over IP. Our Facilities foreman Mike Gawinski has 20 years of mechanical experience and our VP of Operations Theresa Marlow has a background in Medical Management as well as Hospitality operations.

 

Updates

Dan Marlow
Dan Marlow3 years ago

"Separately, researchers at Tel Aviv University have begun developing a CBD-based drug that has been shown to be effective against inflammation for coronavirus-infected lung cells."
https://www.breitbart.com/middle-east/2020/04/25/israeli-hospital-to-begin-treating-virus-patients-with-cannabis/

 

 

Load More

Q&A


Unfortunately, this securities offering is closed. For questions, please email info@fundanna.com. Thanks!

Ruth Whitehead
Ruth Whitehead - Investor2 years ago
What is the current status of the stock?
Robert W Neill Jr
Robert W Neill Jr - Investor2 years ago
What is the current status on this offering?
James,Emily Ware
James,Emily Ware - Investor3 years ago
can i invest my $200 in cbd?
James,Emily Ware
James,Emily Ware - Investor   
i never receiced my investment certificate

3 years ago
Load More

Documents

Start-up Valuation Download
Offering Statement Download

Other Disclosures

Read the Form C filed with the SEC for other important disclosures, like financial statements, Directors, Officers, shareholders with more than 20% of voting rights, and more.
Special Note Regarding Forward-Looking Statements
This offering contains forward-looking statements within the meaning of the federal securities laws. We caution investors that any forward-looking statements presented in this offering, or which management may make orally or in writing from time to time, are based on the Company’s beliefs and assumptions made by, and information currently available to, the Company. When used, the words “anticipate,” “believe,” “expect,” “intend,” “may,” “might,” “plan,” “estimate,” “project,” “should,” “will,” “would,” “result” and similar expressions, which do not relate solely to historical matters, are intended to identify forward-looking statements. Such statements are subject to risks, uncertainties and assumptions and are not guarantees of future performance, which may be affected by known and unknown risks, trends, uncertainties and factors that are beyond the Company’s control. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those anticipated, estimated or projected. While forward-looking statements reflect the Company’s good faith belief when made, they are not guarantees of future performance. The Company expressly disclaims any responsibility to update forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.

Moreover, we operate in a very competitive and rapidly changing environment, and new risks emerge from time to time. It is not possible to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. In light of these risks, uncertainties and assumptions, the forward-looking events and circumstances discussed in this offering may not occur, and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements. We undertake no obligation to revise or publically release the results of any revision to these forward-looking statements, except as required by law. Given these risks and uncertainties, prospective investors are cautioned not to place undue reliance on such forward-looking statements.
up

Back to top